ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BHZPJ890
Stock Name / FundiShares MSCI USA ESG Enhanced UCITS ETF USD (Dist)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity Type
Entity LEI 549300ZP07LMR36K1T02
ETF TickerEEDG(GBP) LSE
ETF TickerEEDS(USD) LSE
ETF TickerEEDG.LS(GBP) CXE
ETF TickerEEDS.LS(USD) CXE
ETF TickerOM3L.DE(EUR) CXE
ETF TickerEEDG.L(GBP) LSE
ETF TickerEEDS.L(GBP) LSE

Holdings detail for ALNY

Stock NameAlnylam Pharmaceuticals Inc
TickerALNY(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS02043Q1076
LEI529900S3ZI14OWRJII50

Show aggregate ALNY holdings

News associated with ALNY

Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Raised to $500.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its target price increased by Royal Bank Of Canada from $435.00 to $500.00 in a report issued on Friday morning,Benzinga reports. They currently have an outperform rating on the biopharmaceutical company’s stock. ALNY has been the topic of several other reports. The Goldman Sachs Group boosted their price […] - 2025-09-22 02:32:43
Alnylam Pharmaceuticals (NASDAQ:ALNY) Given New $520.00 Price Target at Bank of America
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price objective raised by Bank of America from $453.00 to $520.00 in a research report report published on Wednesday,Benzinga reports. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. A number of other equities analysts have also weighed in on ALNY. Oppenheimer upgraded shares […] - 2025-09-18 04:26:54
The Goldman Sachs Group Forecasts Strong Price Appreciation for Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its target price increased by The Goldman Sachs Group from $504.00 to $566.00 in a report published on Tuesday,Benzinga reports. The Goldman Sachs Group currently has a buy rating on the biopharmaceutical company’s stock. Several other equities research analysts have also commented on the stock. Chardan Capital lifted […] - 2025-09-17 03:14:44
Brokerages Set Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) PT at $421.28
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the twenty-seven analysts that are covering the company, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and twenty-three have issued a buy recommendation on the company. The average 1 year target price […] - 2025-09-15 02:47:58
Alnylam Announces Pricing Of Upsized Offering Of $575 Mln Convertible Senior Notes Due 2028
(RTTNews) - Alnylam Pharmaceuticals Inc. (ALNY) announced the pricing of its private offering of $575 million aggregate principal amount of 0.00% convertible senior notes due 2028. The size of the offering was increased from the previously announced offering of $500 million aggre - 2025-09-10 00:33:28
Alnylam Pharma Commences Private Offering Of $500 Mln Of Convertible Senior Notes Due 2028
(RTTNews) - Alnylam Pharmaceuticals Inc. (ALNY) announced that it has commenced a private offering of $500 million aggregate principal amount of convertible senior notes due 2028. In connection with this offering, Alnylam expects to grant the initial purchasers of the notes an op - 2025-09-09 00:30:30
ALNY/RHHBY's Zilebesiran to Enter Phase III After Third Phase II Win
Alnylam and Roche report positive phase II KARDIA-3 results for zilebesiran in high-risk hypertension patients, fueling momentum for a phase III study. - 2025-09-01 11:50:00
Notable ETF Outflow Detected - XBI, ALNY, HALO, INSM
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $119.6 million dollar outflow -- that's a 2.2% decrease week over week - 2025-08-28 11:56:11
Dennis A. Ausiello Sells 31,448 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Stock
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) Director Dennis A. Ausiello sold 31,448 shares of the company’s stock in a transaction on Thursday, August 14th. The shares were sold at an average price of $436.58, for a total value of $13,729,567.84. Following the completion of the sale, the director directly owned 911 shares in […] - 2025-08-18 05:14:55
LPL Financial LLC Buys 2,107 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
LPL Financial LLC grew its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 11.3% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 20,679 shares of the biopharmaceutical company’s stock after acquiring an additional 2,107 shares during the period. LPL Financial LLC’s holdings […] - 2025-08-13 05:04:56
XBI, ALNY, INSM, INCY: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $202.3 million dollar outflow -- that's a 4.3% decrease week over week - 2025-08-12 11:55:54
Cetera Investment Advisers Has $2.17 Million Stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Cetera Investment Advisers raised its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 68.1% during the first quarter, Holdings Channel reports. The firm owned 8,017 shares of the biopharmaceutical company’s stock after purchasing an additional 3,247 shares during the period. Cetera Investment Advisers’ holdings in Alnylam Pharmaceuticals were worth $2,165,000 at the end […] - 2025-08-08 04:44:59
Alnylam Pharmaceuticals (NASDAQ:ALNY) Upgraded at Oppenheimer
Oppenheimer upgraded shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) from a market perform rating to an outperform rating in a research report sent to investors on Monday, Marketbeat.com reports. The brokerage currently has $490.00 target price on the biopharmaceutical company’s stock. ALNY has been the subject of several other reports. Barclays lifted their price […] - 2025-08-07 02:54:47
Alnylam Pharmaceuticals (NASDAQ:ALNY) Upgraded by Wolfe Research to Peer Perform Rating
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) was upgraded by equities research analysts at Wolfe Research from an “underperform” rating to a “peer perform” rating in a research report issued on Monday, Marketbeat reports. A number of other brokerages have also recently issued reports on ALNY. Canaccord Genuity Group lifted their price target on shares […] - 2025-08-06 03:02:54
Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Raised to $400.00 at Chardan Capital
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price objective lifted by Chardan Capital from $325.00 to $400.00 in a research report report published on Friday,Benzinga reports. Chardan Capital currently has a buy rating on the biopharmaceutical company’s stock. Several other research analysts have also issued reports on ALNY. Needham & Company LLC raised their […] - 2025-08-04 02:48:47
Needham & Company LLC Raises Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $478.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price target hoisted by Needham & Company LLC from $377.00 to $478.00 in a research report report published on Thursday morning,Benzinga reports. Needham & Company LLC currently has a buy rating on the biopharmaceutical company’s stock. A number of other research analysts also recently commented on the […] - 2025-08-03 05:28:56
Noteworthy ETF Outflows: XBI, MRNA, ALNY, EXEL
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $225.3 million dollar outflow -- that's a 4.6% decrease week over week - 2025-07-30 11:49:03
Y Intercept Hong Kong Ltd Has $1 Million Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Y Intercept Hong Kong Ltd lessened its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 17.6% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,720 shares of the biopharmaceutical company’s stock after selling 796 shares during the period. […] - 2025-07-25 06:12:53
Victory Capital Management Inc. Cuts Stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Victory Capital Management Inc. lowered its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 5.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,649 shares of the biopharmaceutical company’s stock after selling 2,148 shares during the period. Victory Capital […] - 2025-07-25 05:14:50
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives Average Recommendation of “Moderate Buy” from Brokerages
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the twenty-six research firms that are covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, three have given a hold recommendation and twenty-two have assigned a buy recommendation to the […] - 2025-07-24 06:26:55
Alnylam Pharmaceuticals (NASDAQ:ALNY) Now Covered by Truist Financial
Truist Financial initiated coverage on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a research report sent to investors on Monday, Marketbeat reports. The firm issued a buy rating and a $385.00 price target on the biopharmaceutical company’s stock. A number of other equities research analysts also recently issued reports on ALNY. Jefferies Financial […] - 2025-07-22 03:14:59
Nisa Investment Advisors LLC Cuts Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Nisa Investment Advisors LLC cut its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 38.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,155 shares of the biopharmaceutical company’s stock after selling 5,162 shares during […] - 2025-07-14 05:54:56
Crossmark Global Holdings Inc. Takes Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Crossmark Global Holdings Inc. purchased a new stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 1,018 shares of the biopharmaceutical company’s stock, valued at approximately $275,000. Other hedge funds have also modified their holdings of the […] - 2025-07-14 05:14:48
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Sold by Vontobel Holding Ltd.
Vontobel Holding Ltd. decreased its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 6.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,691 shares of the biopharmaceutical company’s stock after selling 113 shares during the […] - 2025-07-08 04:40:51
Mirae Asset Global Investments Co. Ltd. Sells 2,596 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Mirae Asset Global Investments Co. Ltd. reduced its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 28.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 6,534 shares of the biopharmaceutical company’s stock after selling 2,596 shares during the […] - 2025-07-04 04:52:27
Wells Fargo & Company Raises Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $333.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) had its price target lifted by research analysts at Wells Fargo & Company from $287.00 to $333.00 in a report released on Monday,Benzinga reports. The brokerage presently has an “equal weight” rating on the biopharmaceutical company’s stock. Wells Fargo & Company‘s price objective would suggest a potential upside […] - 2025-07-02 03:05:01
Diversified Trust Co Sells 999 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Diversified Trust Co cut its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 40.3% in the first quarter, Holdings Channel reports. The institutional investor owned 1,482 shares of the biopharmaceutical company’s stock after selling 999 shares during the period. Diversified Trust Co’s holdings in Alnylam Pharmaceuticals were worth $400,000 as of […] - 2025-07-01 07:10:56
Sequoia Financial Advisors LLC Boosts Stock Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Sequoia Financial Advisors LLC lifted its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 3.0% in the first quarter, HoldingsChannel reports. The fund owned 3,395 shares of the biopharmaceutical company’s stock after acquiring an additional 99 shares during the period. Sequoia Financial Advisors LLC’s holdings in Alnylam Pharmaceuticals were worth $917,000 […] - 2025-07-01 05:22:50
Alnylam Pharmaceuticals (NASDAQ:ALNY) Sets New 12-Month High Following Analyst Upgrade
Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) hit a new 52-week high on Monday after Wells Fargo & Company raised their price target on the stock from $287.00 to $333.00. Wells Fargo & Company currently has an equal weight rating on the stock. Alnylam Pharmaceuticals traded as high as $327.05 and last […] - 2025-07-01 02:27:01
Kentucky Retirement Systems Buys New Shares in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Kentucky Retirement Systems bought a new stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 8,794 shares of the biopharmaceutical company’s stock, valued at approximately $2,375,000. Several other institutional investors and […] - 2025-06-24 06:20:52

iShares MSCI USA ESG Enhanced UCITS ETF USD (Dist) ALNY holdings

DateNumber of ALNY Shares HeldBase Market Value of ALNY SharesLocal Market Value of ALNY SharesChange in ALNY Shares HeldChange in ALNY Base ValueCurrent Price per ALNY Share HeldPrevious Price per ALNY Share Held
2025-12-03 (Wednesday)44,341USD 20,986,152ALNY holding increased by 370691USD 20,986,1520USD 370,691 USD 473.29 USD 464.93
2025-12-02 (Tuesday)44,341USD 20,615,461ALNY holding increased by 459816USD 20,615,4610USD 459,816 USD 464.93 USD 454.56
2025-12-01 (Monday)44,341USD 20,155,645ALNY holding increased by 147656USD 20,155,6450USD 147,656 USD 454.56 USD 451.23
2025-11-28 (Friday)44,341ALNY holding decreased by -6USD 20,007,989ALNY holding increased by 268252USD 20,007,989-6USD 268,252 USD 451.23 USD 445.12
2025-11-27 (Thursday)44,347USD 19,739,737USD 19,739,7370USD 0 USD 445.12 USD 445.12
2025-11-26 (Wednesday)44,347ALNY holding increased by 60USD 19,739,737ALNY holding increased by 705184USD 19,739,73760USD 705,184 USD 445.12 USD 429.8
2025-11-25 (Tuesday)44,287USD 19,034,553ALNY holding decreased by -196191USD 19,034,5530USD -196,191 USD 429.8 USD 434.23
2025-11-24 (Monday)44,287ALNY holding increased by 675USD 19,230,744ALNY holding increased by 199339USD 19,230,744675USD 199,339 USD 434.23 USD 436.38
2025-11-21 (Friday)43,612ALNY holding decreased by -30USD 19,031,405ALNY holding decreased by -423762USD 19,031,405-30USD -423,762 USD 436.38 USD 445.79
2025-11-20 (Thursday)43,642USD 19,455,167ALNY holding decreased by -653321USD 19,455,1670USD -653,321 USD 445.79 USD 460.76
2025-11-19 (Wednesday)43,642ALNY holding decreased by -295USD 20,108,488ALNY holding decreased by -203587USD 20,108,488-295USD -203,587 USD 460.76 USD 462.3
2025-11-18 (Tuesday)43,937ALNY holding decreased by -240USD 20,312,075ALNY holding decreased by -33201USD 20,312,075-240USD -33,201 USD 462.3 USD 460.54
2025-11-17 (Monday)44,177ALNY holding increased by 10USD 20,345,276ALNY holding increased by 507226USD 20,345,27610USD 507,226 USD 460.54 USD 449.16
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ALNY by Blackrock for IE00BHZPJ890

Show aggregate share trades of ALNY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-28SELL-6455.755444.430 445.562USD -2,673 315.51 Loss of -780 on sale
2025-11-26BUY60447.690430.270 432.012USD 25,921 314.33
2025-11-26BUY60447.690430.270 432.012USD 25,921 314.33
2025-11-24BUY675444.670420.345 422.778USD 285,375 313.25
2025-11-21SELL-30449.530433.500 435.103USD -13,053 312.68 Loss of -3,673 on sale
2025-11-19SELL-295465.320456.900 457.742USD -135,034 311.37 Loss of -43,179 on sale
2025-11-18SELL-240469.110456.270 457.554USD -109,813 310.67 Loss of -35,253 on sale
2025-11-17BUY10463.750449.000 450.475USD 4,505 309.96
2025-11-14BUY20461.960448.280 449.648USD 8,993 309.31
2025-11-13BUY205456.140447.155 448.054USD 91,851 308.62
2025-11-12SELL-97459.270447.130 448.344USD -43,489 307.93 Loss of -13,620 on sale
2025-11-10SELL-90449.680440.930 441.805USD -39,762 306.60 Loss of -12,169 on sale
2025-11-06BUY4445.490429.000 430.649USD 1,723 305.29
2025-11-05BUY40438.530417.000 419.153USD 16,766 304.66
2025-11-03BUY58457.260429.615 432.379USD 25,078 304.02
2025-10-31BUY20459.570441.220 443.055USD 8,861 303.27
2025-10-30BUY152471.980436.512 440.059USD 66,889 302.55
2025-10-29BUY39481.590482.730 482.616USD 18,822 301.66
2025-10-24BUY690463.430469.290 468.704USD 323,406 300.85
2025-10-22BUY1,030464.900480.530 478.967USD 493,336 300.03
2025-10-20BUY25491.220495.550 495.117USD 12,378 298.17
2025-10-17BUY218481.670492.620 491.525USD 107,152 297.24
2025-10-14SELL-30469.360479.690 478.657USD -14,360 294.50 Loss of -5,525 on sale
2025-10-13BUY5464.950473.650 472.780USD 2,364 293.61
2025-10-06BUY95452.000458.690 458.021USD 43,512 292.78
2025-10-03BUY20456.350465.010 464.144USD 9,283 291.92
2025-10-02BUY20460.990461.530 461.476USD 9,230 291.02
2025-10-01BUY173460.650467.420 466.743USD 80,747 290.12
2025-09-29BUY10447.490451.630 451.216USD 4,512 288.38
2025-09-26SELL-510446.400453.050 452.385USD -230,716 287.53 Loss of -84,077 on sale
2025-09-25BUY275449.580459.000 458.058USD 125,966 286.65
2025-09-18BUY140452.170456.940 456.463USD 63,905 285.74
2025-09-17BUY215451.730463.880 462.665USD 99,473 284.83
2025-09-15BUY109461.140466.240 465.730USD 50,765 282.87
2025-09-12BUY85465.890475.690 474.710USD 40,350 281.85
2025-09-11SELL-270468.580474.340 473.764USD -127,916 280.80 Loss of -52,100 on sale
2025-09-10BUY50469.310480.050 478.976USD 23,949 279.74
2025-09-09BUY65482.130484.210 484.002USD 31,460 278.59
2025-08-27BUY13,182454.180455.450 455.323USD 6,002,068 276.58
2025-08-21BUY6467.550467.710 467.694USD 2,806 274.43
2025-08-19BUY18458.280462.880 462.420USD 8,324 272.27
2025-07-21BUY3320.520328.700 327.882USD 984 271.99
2025-07-18BUY141320.530325.620 325.111USD 45,841 271.70
2025-07-17BUY18324.690329.870 329.352USD 5,928 271.38
2025-07-16BUY315322.810323.410 323.350USD 101,855 271.07
2025-07-15BUY165311.120316.900 316.322USD 52,193 270.83
2025-07-03SELL-24331.910333.700 333.521USD -8,005 270.08 Loss of -1,523 on sale
2025-07-02SELL-186329.770330.000 329.977USD -61,376 269.71 Loss of -11,210 on sale
2025-06-30SELL-3326.090327.210 327.098USD -981 269.36 Loss of -173 on sale
2025-06-27BUY12322.830323.200 323.163USD 3,878 269.02
2025-06-26BUY6318.250325.000 324.325USD 1,946 268.71
2025-06-25BUY12321.940324.320 324.082USD 3,889 268.38
2025-06-24SELL-9325.000326.030 325.927USD -2,933 268.02 Loss of -521 on sale
2025-06-17SELL-12308.710309.060 309.025USD -3,708 266.60 Loss of -509 on sale
2025-06-13SELL-6307.990308.020 308.017USD -1,848 266.04 Loss of -252 on sale
2025-06-12BUY9304.670307.480 307.199USD 2,765 265.78
2025-06-06SELL-42300.830310.220 309.281USD -12,990 264.79 Loss of -1,868 on sale
2025-06-05SELL-66308.000308.530 308.477USD -20,359 264.49 Loss of -2,903 on sale
2025-06-04SELL-87305.310308.930 308.568USD -26,845 264.21 Loss of -3,859 on sale
2025-06-03BUY18303.770307.850 307.442USD 5,534 263.93
2025-06-02SELL-6306.090307.190 307.080USD -1,842 263.63 Loss of -261 on sale
2025-05-30BUY11,821304.560306.000 305.856USD 3,615,524 263.34
2025-05-29SELL-12292.900293.220 293.188USD -3,518 263.13 Loss of -361 on sale
2025-05-28SELL-8285.560291.540 290.942USD -2,328 262.96 Loss of -224 on sale
2025-05-23SELL-36289.960291.220 291.094USD -10,479 262.36 Loss of -1,034 on sale
2025-05-22BUY2289.000291.540 291.286USD 583 262.16
2025-05-21SELL-10292.580298.230 297.665USD -2,977 261.94 Loss of -357 on sale
2025-05-20BUY44291.680292.990 292.859USD 12,886 261.71
2025-05-16SELL-18285.310289.750 289.306USD -5,208 261.30 Loss of -504 on sale
2025-05-15BUY2283.400285.000 284.840USD 570 261.12
2025-05-14BUY36267.550270.000 269.755USD 9,711 261.07
2025-05-13BUY134266.860268.070 267.949USD 35,905 261.03
2025-05-12BUY106270.190270.200 270.199USD 28,641 260.96
2025-05-09BUY34251.150260.000 259.115USD 8,810 261.03
2025-05-08SELL-32258.350270.000 268.835USD -8,603 261.06 Loss of -249 on sale
2025-05-07BUY94276.550277.850 277.720USD 26,106 260.93
2025-05-06BUY22269.810276.470 275.804USD 6,068 260.86
2025-05-02SELL-4259.390265.000 264.439USD -1,058 260.76 Loss of -15 on sale
2025-05-01SELL-2255.130265.910 264.832USD -530 260.81 Loss of -8 on sale
2025-04-28SELL-272254.850256.570 256.398USD -69,740 260.87 Profit of 1,217 on sale
2025-04-25SELL-4251.560253.250 253.081USD -1,012 260.95 Profit of 31 on sale
2025-04-24SELL-62242.610243.690 243.582USD -15,102 261.12 Profit of 1,087 on sale
2025-04-23SELL-22241.970248.590 247.928USD -5,454 261.28 Profit of 294 on sale
2025-04-22SELL-14236.750238.630 238.442USD -3,338 261.50 Profit of 323 on sale
2025-04-16SELL-78230.500234.500 234.100USD -18,260 262.56 Profit of 2,220 on sale
2025-04-11BUY38237.770240.000 239.777USD 9,112 263.31
2025-04-10BUY12226.280235.330 234.425USD 2,813 263.66
2025-04-09BUY20243.270245.560 245.331USD 4,907 263.86
2025-04-08SELL-58224.320246.150 243.967USD -14,150 264.25 Profit of 1,176 on sale
2025-04-07BUY38232.950241.830 240.942USD 9,156 264.56
2025-04-04BUY86235.740259.160 256.818USD 22,086 264.85
2025-04-02BUY34266.830267.290 267.244USD 9,086 264.83
2025-04-01BUY16255.760273.610 271.825USD 4,349 264.92
2025-03-31SELL-86270.020271.850 271.667USD -23,363 264.87 Loss of -585 on sale
2025-03-28SELL-8268.460271.300 271.016USD -2,168 264.83 Loss of -49 on sale
2025-03-26BUY2269.210281.210 280.010USD 560 264.72
2025-03-25BUY6280.960292.620 291.454USD 1,749 264.54
2025-03-24BUY12290.700300.900 299.880USD 3,599 264.26
2025-03-21BUY312283.340289.440 288.830USD 90,115 264.05
2025-03-19SELL-58253.440255.350 255.159USD -14,799 264.29 Profit of 529 on sale
2025-03-17SELL-4253.110253.300 253.281USD -1,013 264.64 Profit of 45 on sale
2025-03-14SELL-8241.760244.040 243.812USD -1,950 264.91 Profit of 169 on sale
2025-03-13SELL-2241.750245.140 244.801USD -490 265.18 Profit of 41 on sale
2025-03-12SELL-8242.430246.370 245.976USD -1,968 265.45 Profit of 156 on sale
2025-03-11BUY2238.740243.450 242.979USD 486 265.78
2025-03-06BUY124248.130252.840 252.369USD 31,294 266.67
2025-03-05SELL-10249.230249.820 249.761USD -2,498 266.89 Profit of 171 on sale
2025-03-03BUY6243.530250.000 249.353USD 1,496 267.51
2025-02-28SELL-10,882246.750249.340 249.081USD -2,710,499 267.78 Profit of 203,477 on sale
2025-02-27SELL-60237.100246.380 245.452USD -14,727 268.19 Profit of 1,364 on sale
2025-02-26SELL-759243.860251.600 250.826USD -190,377 268.52 Profit of 13,428 on sale
2025-02-25SELL-51245.200251.560 250.924USD -12,797 268.84 Profit of 914 on sale
2025-02-24BUY75248.940256.470 255.717USD 19,179 269.11
2025-02-21BUY39250.590253.700 253.389USD 9,882 269.37
2025-02-20BUY9251.000252.990 252.791USD 2,275 269.64
2025-02-19BUY6250.510254.010 253.660USD 1,522 269.91
2025-02-18SELL-33250.000260.000 259.000USD -8,547 270.21 Profit of 370 on sale
2025-02-14BUY9256.450264.870 264.028USD 2,376 270.62
2025-02-13SELL-6264.890268.520 268.157USD -1,609 270.71 Profit of 15 on sale
2025-02-12SELL-114265.960268.200 267.976USD -30,549 270.79 Profit of 320 on sale
2025-02-06BUY15278.250279.240 279.141USD 4,187 270.55
2025-02-05SELL-45276.310278.440 278.227USD -12,520 270.45 Loss of -350 on sale
2025-02-03BUY6274.550278.510 278.114USD 1,669 270.37
2025-01-30SELL-63277.160279.360 279.140USD -17,586 270.23 Loss of -562 on sale
2025-01-28SELL-39279.190283.560 283.123USD -11,042 269.99 Loss of -512 on sale
2025-01-27BUY18276.730287.220 286.171USD 5,151 269.86
2025-01-24BUY33278.760279.670 279.579USD 9,226 269.68
2025-01-23BUY33275.540277.220 277.052USD 9,143 269.57
2024-12-09BUY6255.890258.120 257.897USD 1,547 270.18
2024-12-06BUY93256.260257.810 257.655USD 23,962 270.47
2024-12-04BUY69254.720256.680 256.484USD 17,697 271.24
2024-12-03BUY39251.840253.210 253.073USD 9,870 271.68
2024-12-02BUY90253.010255.290 255.062USD 22,956 272.11
2024-11-29BUY9253.070254.180 254.069USD 2,287 272.57
2024-11-27BUY3253.740256.020 255.792USD 767 273.51
2024-11-26SELL-102253.350253.740 253.701USD -25,878 274.57 Profit of 2,128 on sale
2024-11-26SELL-102253.350253.740 253.701USD -25,878 274.57 Profit of 2,128 on sale
2024-11-25BUY4,868250.980255.460 255.012USD 1,241,398 275.21
2024-11-22SELL-5244.890248.900 248.499USD -1,242 276.05 Profit of 138 on sale
2024-11-21BUY126246.800250.710 250.319USD 31,540 276.88
2024-11-19SELL-27234.270235.940 235.773USD -6,366 279.03 Profit of 1,168 on sale
2024-11-18BUY60232.270242.490 241.468USD 14,488 280.49
2024-11-12BUY3268.950270.770 270.588USD 812 280.86
2024-11-08BUY9277.430279.510 279.302USD 2,514 281.14
2024-11-08BUY9277.430279.510 279.302USD 2,514 281.14
2024-11-07BUY231272.220275.070 274.785USD 63,475 281.83
2024-11-07BUY231272.220275.070 274.785USD 63,475 281.83
2024-11-06BUY6273.010278.210 277.690USD 1,666 282.56
2024-11-06BUY6273.010278.210 277.690USD 1,666 282.56
2024-11-05SELL-15265.290268.890 268.530USD -4,028 284.13 Profit of 234 on sale
2024-11-05SELL-15265.290268.890 268.530USD -4,028 284.13 Profit of 234 on sale
2024-11-04SELL-108269.950272.920 272.623USD -29,443 285.55 Profit of 1,396 on sale
2024-11-04SELL-108269.950272.920 272.623USD -29,443 285.55 Profit of 1,396 on sale
2024-11-01SELL-30273.910274.030 274.018USD -8,221 286.84 Profit of 385 on sale
2024-11-01SELL-30273.910274.030 274.018USD -8,221 286.84 Profit of 385 on sale
2024-10-31BUY17266.590276.000 275.059USD 4,676 289.38
2024-10-31BUY17266.590276.000 275.059USD 4,676 289.38
2024-10-30SELL-114281.490287.870 287.232USD -32,744 290.50 Profit of 373 on sale
2024-10-30SELL-114281.490287.870 287.232USD -32,744 290.50 Profit of 373 on sale
2024-10-29SELL-108284.690287.020 286.787USD -30,973 291.47 Profit of 506 on sale
2024-10-29SELL-108284.690287.020 286.787USD -30,973 291.47 Profit of 506 on sale
2024-10-28BUY9286.910290.940 290.537USD 2,615 292.38
2024-10-28BUY9286.910290.940 290.537USD 2,615 292.38
2024-10-25BUY192284.860293.740 292.852USD 56,228 294.26
2024-10-25BUY192284.860293.740 292.852USD 56,228 294.26
2024-10-24BUY24293.690301.050 300.314USD 7,208 294.45
2024-10-24BUY24293.690301.050 300.314USD 7,208 294.45
2024-10-23SELL-4294.870299.170 298.740USD -1,195 294.25 Loss of -18 on sale
2024-10-23SELL-4294.870299.170 298.740USD -1,195 294.25 Loss of -18 on sale
2024-10-22BUY21296.480297.510 297.407USD 6,246 292.01
2024-10-22BUY21296.480297.510 297.407USD 6,246 292.01
2024-10-21SELL-210292.010295.390 295.052USD -61,961 0.00 Loss of -61,961 on sale
2024-10-21SELL-210292.010295.390 295.052USD -61,961 0.00 Loss of -61,961 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ALNY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19216,7273,259396,24354.7%
2025-09-18172,875397386,43244.7%
2025-09-17246,547167472,29252.2%
2025-09-1688,84660226,33639.3%
2025-09-15148,25813,572435,68934.0%
2025-09-12134,122300244,96854.8%
2025-09-11219,8687,820411,70253.4%
2025-09-10543,3267,595916,89859.3%
2025-09-09705,54033,7311,550,89945.5%
2025-09-08175,158440388,71545.1%
2025-09-05127,116335311,25240.8%
2025-09-04110,9302,555236,56846.9%
2025-09-03182,3868,982562,92132.4%
2025-09-02132,77014,416358,47637.0%
2025-08-2993,2162,181276,59433.7%
2025-08-2860,1821,254226,86526.5%
2025-08-27277,6671,084440,57763.0%
2025-08-26243,404919447,42154.4%
2025-08-25156,55115,662374,27641.8%
2025-08-22228,5961,309408,15256.0%
2025-08-21123,9962,862248,30049.9%
2025-08-20149,63813,723316,98347.2%
2025-08-19144,3201,143308,39946.8%
2025-08-18371,31834,264525,78670.6%
2025-08-15104,01813,245265,62039.2%
2025-08-14133,2724,443505,52826.4%
2025-08-13183,2711,3901,017,62318.0%
2025-08-12173,0454,046693,01825.0%
2025-08-11239,1997,600451,24853.0%
2025-08-08168,7553,199466,74436.2%
2025-08-07308,8104,452527,39958.6%
2025-08-06202,15112,590548,34936.9%
2025-08-05256,29513,237826,28331.0%
2025-08-04411,11436,303729,94956.3%
2025-08-01350,06060,108764,94345.8%
2025-07-31829,1916,0231,541,01553.8%
2025-07-30533,88514,703942,78856.6%
2025-07-29164,26855384,53742.7%
2025-07-28150,24069571,96526.3%
2025-07-2590,782429298,80130.4%
2025-07-24132,00111,546286,15546.1%
2025-07-23184,14963312,34059.0%
2025-07-22134,7617,553524,61225.7%
2025-07-21113,303101243,11946.6%
2025-07-1884,1179196,31742.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy